Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
United Kingdom
Countries of investment
  • United Kingdom
  • USA
Investment stages
  • Seed
Industries
  • Biotechnology
  • Health Tech
  • AI
About
Epidarex Capital is a transatlantic venture capital firm that focuses on investing in early-stage, high-growth life science and health technology companies in under-ventured markets, particularly within the UK and emerging hubs.
Min check size
$500K
Max check size
$2M
Fund size
NPS

Investment Thesis

Epidarex invests in earlystage, highgrowth life science companies in emerging and underventured research hubs within the US and United Kingdom. They focus on disruptive platform technologies that address large and unmet medical needs, offering a sustainable competitive advantage.
Lead investor
Co Invest
Number of exits
Preferred contact method

Epidarex Contacts Information

Primary contact

Secondary contact

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp